Osteoporosis is a systemic metabolic disease, mainly characterized by reduced bone
mineral density and destruction of bone tissue microstructure. However, the molecular …

An update is available for this article. Description: This guideline updates the 2017 American
College of Physicians (ACP) recommendations on pharmacologic treatment of primary …

Osteoporosis affects more than 200 million women worldwide, with postmenopausal women
being particularly susceptible to this condition and its severe sequelae disproportionately …

Background Osteoporosis (OP), often referred to as the “silent disease of the twenty-first
century,” poses a significant public health concern due to its severity, chronic nature, and …

OBJECTIVE: This study aims to compare the efficacy and safety of denosumab, teriparatide,
zoledronic acid, and ibandronic acid for the treatment of women with postmenopausal …

Background The relationship between obesity and bone mineral density (BMD) varies in
different studies. Our aim in this study was to explore the association between obesity (body …

Introduction The objective of this systematic review and meta-analysis is to systematically
identify and review the efficacy of pharmacological treatments in men with osteoporosis …

Background With the increasing incidence of osteoporosis, vitamin K and calcium have
been linked to bone mineral density (BMD) and undercarboxylated osteocalcin (UcOC) in …

Accumulation of lipid substances decreased the activity of osteoblasts. Trehalose is a typical
stress metabolite to form a protective membrane on cell surface which has been …

Introduction Pharmacological strategies might influence bone healing in terms of time to
union or quality of mature bone. This expert opinion discussed the current level I evidence …